- Open Access
Atelectasis causes alveolar hypoxia-induced inflammation during uneven mechanical ventilation in rats
Intensive Care Medicine Experimental volume 3, Article number: 18 (2015)
Patients with acute respiratory distress syndrome receiving mechanical ventilation show inhomogeneous lung aeration. Atelectasis during uneven mechanical ventilation leads to alveolar hypoxia and could therefore result in lung inflammation and injury. We aimed to elucidate whether and how atelectasis causes alveolar hypoxia-induced inflammation during uneven mechanical ventilation in an open-chest differential-ventilation rat model.
We first investigated inflammatory and histological changes in the bilateral lungs of unilaterally ventilated rats, in which the right lung was atelectatic and the left lung was ventilated with high tidal volume (HTV). In the next series, we investigated the effects of normal tidal volume (NTV) ventilation of the right lungs with 60 % O2 or 100 % N2 during HTV ventilation of the left lungs. Then, proinflammatory cytokine secretions were quantified from murine lung epithelial (MLE15) and murine alveolar macrophage (MH-S) cells cultured under a hypoxic condition (5 % O2) mimicking atelectasis. Further, activities of nuclear factor (NF)-κB and hypoxia-inducible factor (HIF)-1 were assessed in the nonventilated atelectatic lung and MLE15 cells cultured under the hypoxic condition. Finally, effects of NF-κB inhibition and HIF-1α knockdown on the cytokine secretions from MLE15 cells cultured under the hypoxic condition were assessed.
The nonventilated atelectatic lungs showed inflammatory responses and minimal histological changes comparable to those of the HTV-ventilated lungs. NTV ventilation with 60 % O2 attenuated the increase in chemokine (C-X-C motif) ligand (CXCL)-1 secretion and neutrophil accumulation observed in the atelectatic lungs, but that with 100 % N2 did not. MLE15 cells cultured with tumor necrosis factor (TNF)-α under the hypoxic condition showed increased CXCL-1 secretion. NF-κB and HIF-1α were activated in the nonventilated atelectatic lungs and MLE15 cells cultured under the hypoxic condition. NF-κB inhibition abolished the hypoxia-induced increase in CXCL-1 secretion from MLE15 cells, while HIF-1α knockdown augmented it.
Atelectasis causes alveolar hypoxia-induced inflammatory responses including NF-κB-dependent CXCL-1 secretion from lung epithelial cells. HIF-1 activation in lung epithelial cells is an anti-inflammatory response to alveolar hypoxia in atelectatic lungs.
Patients with acute respiratory distress syndrome receiving mechanical ventilation show inhomogeneous lung aeration. Dependent atelectatic regions are poorly aerated while nondependent aerated regions are ventilated with relatively high tidal volume (HTV). HTV ventilation of nondependent regions causes overinflation and barotrauma . Moreover, peri-atelectatic regions augment mechanical stress , and repetitive shear stress caused by alveolar collapse and re-opening deteriorates lung injury [3–5]. Notably, alveolar O2 tension rapidly decreases to a mixed venous level in atelectatic lungs , leading to alveolar hypoxia, a potent inducer of lung inflammation . Therefore, atelectasis could deteriorate ventilator-associated lung injury (VALI) by alveolar hypoxia-induced inflammation during uneven mechanical ventilation. However, the role of atelectasis in VALI is not fully elucidated.
Nuclear factor (NF)-κB and hypoxia-inducible factor (HIF)-1 are transcription factors that regulate hypoxic inflammation [8, 9]. NF-κB has a central role in the transcription of proinflammatory mediators, responsible for inflammatory diseases including lung injury . It is inactive when bound to inhibitors of κB (IκB) in the cytoplasm, but IκB phosphorylation by IκB kinase leads to liberation and nuclear translocation of NF-κB. Hypoxia activates IκB kinase through inhibition of prolyl hydroxylase (PHD)-1 and enhances nuclear translocation of NF-κB . HIF-1 is a heterodimer consisting of HIF-1α and HIF-1β. In normoxic conditions, specific proline residues of HIF-1α are hydroxylated by PHD and HIF-1α is ubiquitinated and degraded, while HIF-1β is constitutively present in excess. Hypoxia inhibits HIF-1α hydroxylation by PHD and activates HIF-1. HIF-1 is a key regulator of hypoxic responses and modulates transcription of numerous genes associated with adaptation to hypoxia . It also plays essential roles in regulating inflammation [13–17].
To elucidate whether and how atelectasis causes alveolar hypoxia-induced inflammation, we used an open-chest differential-ventilation rat model. First, we investigated inflammation and histological changes in the bilateral lungs of unilaterally ventilated rats, in which the right lung was atelectatic and the left lung was ventilated with HTV. Next, we investigated the effects of normal tidal volume (NTV) ventilation of the right lungs with 60 % O2 (nonhypoxic condition) or 0 % O2 (hypoxic condition) during HTV ventilation of the left lungs. Then, we studied the responses of two potent sources of inflammatory mediators in the lungs: lung epithelial and alveolar macrophage cells, under a hypoxic condition mimicking atelectasis. To clarify the mechanisms of lung injury, we investigated the roles of NF-κB and HIF-1 in hypoxia-induced inflammatory responses in lung epithelial cells.
The Animal Research Committee of Yokohama City University approved the animal experiments. Specific pathogen-free male Sprague–Dawley rats aged 9–10 weeks and weighing 300–400 g were used. The animals were housed under a 12-h light/dark cycle with unrestricted access to food and water.
The animals were anesthetized with an intraperitoneal injection of sodium pentobarbital (16 mg), and 0.5 % bupivacaine was injected into the surgical site for analgesia. The right carotid artery and femoral vein were catheterized. Lactated Ringer’s solution containing 0.5 % sodium pentobarbital was continuously injected (4 mL/kg/h) via the right femoral vein. Body temperature was maintained between 36.5 and 38.0 °C by placing the rats on a warming device. After tracheotomy, a 16-gauge plastic cannula processed with a broadened tip was inserted into the trachea. After administration of 1-mg pancuronium bromide and initiation of mechanical ventilation, bilateral thoracotomy was performed to visualize the lungs.
Rats were assigned to one of two ventilation protocols (eight animals per protocol): bilateral lung ventilation (BLV) and unilateral lung ventilation (ULV). BLV was initiated and maintained by using a constant-volume pump (SN-480-7, Shinano Seisakusho, Tokyo, Japan) with the following parameters: tidal volume, 8 mL/kg; frequency, 80/min; and positive end-expiratory pressure (PEEP), 4 cmH2O. For ULV, the 16-gauge tracheal cannula was advanced into the left main bronchus and the left lung was ventilated with the same parameter setting for BLV: tidal volume, 8 mL/kg; frequency, 80/min; and PEEP, 4 cmH2O. Immediately thereafter, a 20-gauge plastic cannula was inserted into the trachea through the tracheotomy site in the ULV group. The gap between the cannula and the trachea was sealed with instant adhesive (Aron Alpha, Toagosei, Tokyo, Japan) to prevent air leakage. The 20-gauge tracheal cannula was open to atmospheric pressure, and the right lung was collapsed. The inspired O2 fraction of the ventilated lungs was 1.0 during the first hour to prevent severe hypoxemia before establishment of hypoxic pulmonary vasoconstriction and then reduced to 0.6. Before and every 1 h after the ventilation protocols were applied, the ventilated lungs were inflated at 30 cmH2O for 5 s to prevent atelectasis.
In the next series of experiments, we evaluated the effects of NTV ventilation of right lungs with different gaseous mixtures during HTV ventilation of the left lungs. Rats were assigned to one of three ventilation protocols: ULV, NTV60 %, and NTV0 %. In all the groups, the left lung was ventilated through the 16-gauge cannula in the left main bronchus with the following parameters: tidal volume, 8 mL/kg; frequency, 80/min; and PEEP, 4 cmH2O. The ventilation protocol of the ULV group was the same to that of the first series experiment. For NTV ventilation of the right lung, the 20-gauge tracheal cannula was connected to another constant-volume pump and the right lung was ventilated with the following parameters: tidal volume, 4 mL/kg; frequency, 80/min; and PEEP, 4 cmH2O. The inspired O2 fraction of the right NTV lung was either 60 or 0 % O2 (100 % N2).
Mean arterial pressure (MAP) and peak airway pressure (P aw) were recorded, and arterial blood was collected for blood gas analysis before and every 2 h after the ventilation protocols, and the volume of blood obtained was replaced with the same volume of 6 % hydroxyethyl starch solution (Hespander, Fresenius Kabi Japan, Tokyo, Japan). After 8 h of ventilation, the rats were deeply anesthetized and euthanized by exsanguination from the right carotid artery. Their pulmonary vessels were flushed with 50 mL of ice-cold normal saline containing 0.3-mM ethylenediaminetetraacetic acid by gravity infusion at 30 cmH2O via the right ventricle, and the lungs were excised.
Murine lung epithelial (MLE15) and murine alveolar macrophage (MH-S) cells were plated on 12-well plates (2.5 × 105 cells per well ) and cultured in RPMI-1640 (Nacalai Tesque, Tokyo, Japan) supplemented with 4 and 10 % fetal bovine serum (FBS), respectively, for 24 h. The cells were then FBS-starved for 12 h. Subsequently, the culture medium was exchanged to FBS-free medium with or without 500 pg/mL tumor necrosis factor (TNF)-α (PeproTech, Rocky Hill, NJ) to simulate a sterile inflammatory environment, and the cells were cultured in either 21 % (nonhypoxic condition) or 5 % (hypoxic condition) O2 by using CulturePal5 (Mitsubishi Gas Chemical Company, Tokyo, Japan) for 24 h. Conditioned medium was collected and centrifuged at 3000g for 10 min at 4 °C. The supernatants were aliquoted and stored at −80 °C until use. Finally, the cells were lysed for either protein or RNA extraction.
Lung tissues were fixed in paraformaldehyde and embedded in paraffin as described previously , and their sections were stained with hematoxylin and eosin. A pathologist blinded to the allocation of the ventilation protocols assessed and scored the degree of lung histological changes. Perivascular and peribronchial edema, infiltration of leukocytes into the alveolar spaces, and leukocyte stasis and attachment to the intima of the vascular walls were independently scored as 0, none; 1, mild-to-moderate; or 2, severe. The sum of each score (range, 0 to 6) was defined as the histological score.
Frozen lung blocks were homogenized in 10 volumes of phosphate-buffered saline containing 0.5 % Triton-X and 1.0 % proteinase inhibitor cocktail (25954–21, Nacalai Tesque) on ice and centrifuged at 10,000g for 10 min at 4 °C. The supernatants were aliquoted and stored at −80 °C until use. The concentrations of TNF-α (DY510, R&D Systems, Minneapolis, MN), chemokine (C-X-C motif) ligand (CXCL)-1 (DY515, R&D Systems), chemokine (C-C motif) ligand (CCL)-2 (900-M59, PeproTech), and myeloperoxidase (MPO) (DY3667, R&D Systems) were determined by enzyme-linked immunosorbent assay (ELISA). The values were normalized to the total protein concentration measured by a BCA protein assay kit (Thermo Fisher Scientific, Yokohama, Japan).
CXCL-1 (DY453, R&D Systems), CCL-2 (900-K126, PeproTech), and TNF-α (DY410, R&D Systems) in cell-culture supernatants were quantified by ELISA according to the manufacturers’ instructions. Each cytokine concentration was normalized to the relative cell density determined by naphthol blue-black staining.
For HIF-1, lung tissues were homogenized in RIPA buffer (ab156034, Abcam, Cambridge, UK) and sonicated on ice. Cultured cells were washed with ice-cold PBS twice and lysed with ice-cold RIPA buffer for 1 h on ice. Lung tissue homogenates and cell lysates were centrifuged at 10,000g for 10 min at 4 °C, and HIF-1α in the supernatants was quantified by ELISA (DY-1935, R&D Systems).
NF-κB p65 binding activity assay
The NF-κB p65 binding activities of whole cell lysates of lung tissues were quantified by ELISA (TransAM NFκB p65, Active Motif, Carlsbad, CA). Those of nuclear proteins extracted from cultured cells by using the NE-PER Nuclear and Cytoplasmic Extraction Reagent Kit (Thermo Fisher Scientific) were also quantified by ELISA (10007889, Cayman Chemical, Ann Arbor, MI). The activities were normalized to the total protein concentration.
RNA was extracted from frozen lung blocks by using Sepasol-RNA Super G (Nacalai Tesque) and from cultured cells by using RNA extraction columns (NucleoSpin RNA II, Takara Bio, Shiga, Japan). Reverse transcription-PCR was performed to obtain cDNA. Then, reverse transcription-quantitative polymerase chain reaction (qPCR) was performed by using SYBR Premix ExTaq (Takara Bio) with specific primers (Life Technologies Japan, Tokyo, Japan) (Table 1) under the following conditions: 30 s at 95 °C and 40 cycles for 5 s at 95 °C and 30 s at 60 °C (iCycler, Bio-Rad Laboratories, Hercules, CA). Changes in HIF1A, vascular endothelial growth factor A (VEGFA), and glucose transporter-1 (GLUT1) mRNA expressions relative to β-actin (ACTB) mRNA expression were calculated.
NF-κB inhibition and HIF-1α knockdown
To inhibit NF-κB activity, 10 nM of Bay 11–7082 (Wako Pure Chemical Industries, Osaka, Japan), a selective IκB kinase inhibitor, was administered 1 h before the hypoxic challenge in MLE15 cells. For HIF-1α knockdown, MLE15 cells were transfected with HIF-1α small interfering RNA (siRNA) (siGENOME Mouse Hif1a siRNA SMARTpool, Thermo Fisher Scientific) by using Lipofectamine RNAiMAX (Life Technologies Japan). Control cells were transfected with nontarget siRNA (siGENOME Non-Targeting siRNA Pool #1, Thermo Fisher Scientific). Before the experiments, the cells were incubated in a transfection mixture for 24 h followed by incubation in FBS-free medium for 12 h.
Data are presented as means ± SEM or medians (interquartile ranges). Two-way repeated-measures analysis of variance (ANOVA) followed by Student’s t test with Bonferroni correction was performed to compare the BLV and ULV groups. Histological scores were analyzed with Kruskal–Wallis test followed by Dunn’s multiple comparison test. One-way ANOVA followed by Dunnett’s test was performed to compare the ULV, NTV60 %, and NTV0 % groups. Student’s t test was performed to compare cell-culture findings. Two-way ANOVA followed by Student’s t test with Bonferroni correction was performed for multiple comparisons of the cell-culture experiments. Cytokine concentrations were analyzed after performing log transformations to adjust the standard deviations. GraphPad Prism 6 (GraphPad Software, La Jolla, CA) was used for all statistical analyses. Statistical significance was set at p < 0.05.
Mean arterial pressure, peak airway pressure, and arterial blood gas analysis
MAP was not significantly different between the groups until 360 min; however, it was lower in the ULV group than in the BLV group at 480 min (70 ± 18 vs. 98 ± 20 mmHg, p = 0.0444) (Fig. 1a). The peak P aw was higher in the ULV group than that in the BLV group (Fig. 1b). Arterial partial pressure of O2 (PaO2) was significantly higher in the BLV group than that in the ULV group at all the time points after the initiation of ventilation protocols (Fig. 1c). Arterial partial pressure of CO2 (PaCO2) was not significantly different between these groups (Fig. 1d).
Inflammatory mediators in lung homogenates
TNF-α, CXCL-1, CCL-2, and MPO were detected in lung homogenates of the BLV group (Fig. 2). ULV significantly increased the levels of TNF-α (F(1, 14) = 72.87, p < 0.0001) (Fig. 2a) and CXCL-1 (F(1, 14) = 28.53, p < 0.0001) (Fig. 2b) in bilateral lungs. The degrees of increases in TNF-α and CXCL-1 were similar in the bilateral lungs of the ULV group (effect of interaction F(1, 14) = 0.9889, p = 0.3669, and F(1, 14) = 0.8173, p = 0.3813, respectively). No significant change in the CCL-2 level was observed between the two groups (Fig. 2c). The CCL-2 level was significantly increased in the left HTV-ventilated lungs compared to the right atelectatic lung in the ULV group (p = 0.0365). Consistent with the change in the level of CXCL-1: a potent neutrophil chemoattractant, the concentration of MPO: an indicator of neutrophil accumulation, was significantly higher in the bilateral lungs of the ULV group compared to that in the BLV group (p < 0.0001) (Fig. 2d). Moreover, the concentration of MPO was significantly higher in the right atelectatic lung than that in the left HTV-ventilated lung in the ULV group (p = 0.0022).
In the BLV group, almost-normal structures were noted in both lungs (Fig. 3a, b). Perivascular and peribronchial edema, leukocytic infiltration of alveolar spaces, and leukocyte stasis and attachment to the tunica intima of the vascular walls were modestly observed in the ULV group, especially in the right atelectatic lung (Fig. 3c, d, e). However, the histological changes were relatively minimal and other indicative features of lung injury, such as formation of hyaline membranes, presence of proteinaceous debris in the alveolar space, or thickening of the alveolar wall , were not observed. The histological scores were not significantly different between the BLV and ULV groups (Fig. 3f).
NF-κB and HIF-1 activities
NF-κB p65 binding activities are increased in the atelectatic lungs of the ULV group compared with the BLV group (2.01 ± 0.30 vs. 1.00 ± 0.09, p = 0.0070) (Fig. 4a). HIF-1α concentrations (3658 ± 311.6 vs. 1249 ± 186.7 pg/g protein, p < 0.0001) (Fig. 4b) and mRNA levels of HIF-1 downstream genes VEGFA (2.630 ± 0.3778 vs. 1.000 ± 0.1227, p = 0.0011) (Fig. 4c) and GLUT1 (2.000 ± 0.4276 vs. 1.000 ± 0.1423, p = 0.0436) (Fig. 4d) were also significantly increased in these lungs of the ULV group.
Effects of NTV ventilation with 60 % O2 or 100 % N2 on lung inflammation
NTV ventilation of the right lungs with 60 % O2 or 100 % N2 did not significantly alter the TNF-α level compared to the ULV group (Fig. 5a). NTV ventilation with 60 % O2 significantly attenuated the increase in CXCL-1 (562.5 ± 156.7 vs. 225.1 ± 36.31 pg/mg protein, p = 0.0243) and MPO (115.6 ± 7.212 vs. 87.73 ± 6.375 ng/mg protein, p = 0.0148) levels observed in the ULV group (Fig. 5b, c). No significant changes in CXCL-1 (562.5 ± 156.7 vs. 347.4 ± 44.36 pg/mg protein, p = 0.3644) and MPO (115.6 ± 7.212 vs. 109.9 ± 4.834 ng/mg protein, p = 0.7445) concentrations were observed between the atelectatic lungs of the ULV group and the lungs ventilated with 100 % N2. NF-κB p65 binding activity and the concentration of HIF-α were decreased in the NTV60 % group compared to the ULV group (Fig. 5d, e). The concentration of HIF-1α was significantly increased in the NTV0 % group compared to that in the ULV group.
Cytokine secretion in vitro
Next, we investigated the effects of hypoxia on cytokine secretion from murine lung epithelial (MLE15) and alveolar macrophage (MH-S) cells. We treated these cells with TNF-α because TNF-α is known as an essential mediator for the pathogenesis of VALI [20, 21] and the concentration of TNF-α was not affected by NTV ventilation with 60 % O2 in our in vivo experiment. MLE15 cells cultured in 5 % O2 secreted a significantly higher concentration of CXCL-1 than those cultured in 21 % O2 after treatment with TNF-α (5568 ± 279.7 vs.6897 ± 475.7 pg/mL, p = 0.012) (Fig. 6a); no significant difference was noted in MLE15 cells not treated with TNF-α. Further, the concentration of CCL-2 secreted from MH-S cells was not significantly different in any culture condition (Fig. 6b).
TNF-α was not detected in the supernatants of MLE15 or MH-S cells, and CXCL-1 was not detected in the supernatants of MH-S cells. CCL-2 was detected in MLE15 cell supernatants only after TNF-α treatment and at a much lower level than that observed in the MH-S cell supernatants (data not shown).
Exposure to 5 % O2 significantly increased the binding activity of NF-κB p65 in MLE15 cells cultured with TNF-α (1.49 ± 0.14 in 5 % O2 vs. 1.00 ± 0.14 in 21 % O2, p = 0.0367) (Fig. 6c). HIF-1α concentrations (97.1 ± 4.5 pg/mg protein in 5 % O2 vs. 44.5 ± 0.31 pg/mg protein in 21 % O2, p < 0.0001) (Fig. 6d) and VEGFA (1.88 ± 0.22 in 5 % O2 vs. 1.00 ± 0.11 in 21 % O2, p = 0.0071) (Fig. 6e) and GLUT1 (2.83 ± 0.66 in 5 % O2 vs. 1.00 ± 0.11 in 21 % O2, p = 0.0252) (Fig. 6f) mRNA expressions also increased in MLE15 cells cultured with TNF-α under the hypoxic condition.
Roles of NF-κB and HIF-1 in hypoxia-induced inflammatory responses
NF-κB inhibition by Bay 11–7082 abolished the hypoxia-induced upregulation of CXCL-1 in MLE15 cells cultured with TNF-α (two-way ANOVA: effect of oxygen concentration F(1, 20) = 10.53, p = 0.0041; effect of NF-κB inhibition F(1, 20) = 40.73, p < 0.0001; interaction F(1, 20) = 7.122, p = 0.0148; post hoc analysis: 21 vs. 5 % O2 in vehicle group, p = 0.0018; 21 vs.5 % O2 in Bay 11–7082 group, p > 0.9999) (Fig. 7a). HIF-1α knockdown effectively decreased HIF1A, VEGFA, and GLUT1 mRNA levels (Fig. 7b) and the HIF-1α protein concentration (Fig. 7c). However, it increased CXCL-1 secretion from MLE15 cells cultured with TNF-α (two-way ANOVA: effect of oxygen concentration F(1, 20) = 9.401, p = 0.0061; effect of HIF-1α knockdown F(1, 20) = 21.38, p = 0.0002; interaction F(1, 20) = 3.665, p = 0.0700) (Fig. 7d).
In this study, we demonstrated increases of proinflammatory cytokines and neutrophil accumulation in nonventilated atelectatic lungs during ULV. Improvement in alveolar hypoxia by NTV ventilation with 60 % O2 significantly attenuated these inflammatory responses; however, NTV ventilation with 0 % O2 did not. These results suggest that alveolar hypoxia in atelectasis causes inflammation and may contribute to VALI. Moreover, our in vitro results suggest that hypoxia-induced NF-κB activation is responsible for increased CXCL-1 secretion from lung epithelial cells in atelectatic lungs, while HIF-1 negatively regulates CXCL-1 secretion under hypoxic conditions.
The concentrations of inflammatory cytokines in the atelectatic lungs were comparable to those in the HTV-ventilated lungs. Moreover, MPO levels were significantly higher in the atelectatic lungs than in the HTV-ventilated lungs. These data suggest that the inflammatory responses in the atelectatic lungs were caused by atelectasis rather than indirectly by contralateral HTV ventilation. There are conflicting reports regarding the topography of lung inflammation during mechanical ventilation. A previous report has demonstrated predominant inflammation in the aerated overinflated regions in rats with surfactant depletion . We used a relatively lower tidal volume and peak P aw compared with that study , which used 24 mL/kg tidal ventilation without limitation of peak P aw. Therefore, the injurious effects of HTV and overinflation may have been minimal in the present study. Recently, it has been reported that injurious ventilation with 0 cmH2O PEEP and limitation of peak P aw induces predominant inflammation in the dependent lungs of sheep with LPS-induced lung injury . It is possible that uneven mechanical ventilation with moderate HTV ventilation of the nondependent lung, which is often encountered in clinical settings, may cause predominant inflammation in the dependent atelectatic lung.
Our ULV protocol did not cause severe lung histological damage, and the alveolar integrity was maintained. These findings are consistent with our previous report  which demonstrated that HTV ventilation (24 mL/kg) does not cause severe lung injury without concomitant systemic inflammation induced by hepatic ischemia–reperfusion in rats. The inflammatory responses that we observed are possible early events of VALI. These inflammatory responses may not only be reversible  but may also lead to severe injury when other multiple injurious events have occurred.
We used 60 % O2 for nonhypoxic condition because 60 % O2 does not show evident toxicity in healthy animals and is considered to be clinically safe in humans . Meanwhile, it has been reported that exposure of mice with LPS-induced lung injury to 60 % O2 exaggerates the lung injury . In the present study, bilateral lung ventilation in healthy rats with 60 % O2 for 8 h did not cause evident inflammation and injury. Moreover, we demonstrated that NTV ventilation with 60 % O2 significantly attenuated the inflammation in the atelectatic lung; however, anoxic ventilation did not. Although hyperoxia is harmful to lungs, alveolar hypoxia in the nonaerated, atelectatic lungs also seems to be a cause of pulmonary inflammation and may contribute to VALI.
The CXCL-1 concentration was not statistically different between the atelectatic lung and the NTV-ventilated lung with 0 % O2. However, the CXCL-1 concentration tended to decrease in the NTV0 % group. There are some possible explanations for this apparent decrease. First, the HIF-1 concentration was elevated in the right lungs of the NTV0 % group compared with those of the ULV group, although there was no difference in NF-kB DNA-binding activity. The anti-inflammatory effects of HIF-1 may have contributed to the decreased level of CXCL-1 in the NTV0 % group. Second, the mechanical inflation effect of NTV ventilation may have attenuated the CXCL-1 elevation. Although, the precise mechanisms are unclear, mechanical inflation can attenuate lung injury induced by ischemia–reperfusion [26, 27]. However, alveolar hypoxia appears to be the main cause of inflammation in atelectatic lungs because NTV ventilation with 60 % O2 attenuated the inflammation more prominently than those with 0 % O2 did,
The open-chest differential-ventilation rat model offers some advantages. First, we could investigate the effects of atelectasis in nonventilated lungs without repetitive shear stress caused by alveolar collapse and reopening [3–5]. Therefore, we could demonstrate that alveolar hypoxia is one of the main causes of lung inflammation in atelectatic lungs. Second, in a previous study of the effects of alveolar hypoxia on lung inflammation , mice exposed to a hypoxic condition developed systemic hypoxemia. Systemic hypoxemia may have different effects to those of alveolar hypoxia. We could induce alveolar hypoxia, which is clinically more common in lung injury, and evaluate its effects without severe systemic hypoxemia.
Our in vitro data suggest that alveolar epithelial cells contribute to hypoxia-induced inflammation in lungs. In contrast, we did not detect hypoxia-induced inflammatory responses in alveolar macrophages in vitro. The absence of changes of CCL-2 concentration in the atelectatic lung is consistent with the in vitro data. Previous studies have demonstrated that hypoxia-induced CCL-2 release from alveolar macrophages leads to systemic inflammation [29, 30]. According to these reports, CCL-2 release from alveolar macrophages occurs early (15 min to 1 h) after exposure to hypoxia. Therefore, it is possible that the evaluation time points we used in this study did not allow us to detect increased CCL-2 release from alveolar macrophages.
The NF-κB pathway is required for hypoxia-induced inflammatory gene expression , and inhibition of NF-κB activity attenuates hypobaric hypoxia-induced lung edema . Our finding that NF-κB activation is responsible for hypoxia-induced increase in CXCL-1 secretion from lung epithelial cells is consistent with these previous studies [31, 32]. Regarding HIF-1, HIF-1α is essential for myeloid cell-mediated inflammation , and HIF-1α deletion from the myeloid cell lineage attenuates lipopolysaccharide-induced sepsis in mice and raises survival rates . HIF1A mRNA expression is increased in shock patients , and decreased HIF1A mRNA expression in patients with sepsis may be associated with depressed immune function . Moreover, drugs inhibiting HIF-1 activities attenuate lipopolysaccharide-induced lung injury [35, 36]. However, some reports suggest that HIF-1 has anti-inflammatory effects. Targeted deletion of HIF-1α in T lymphocytes in mice with bacterial sepsis leads to higher levels of proinflammatory cytokines and stronger antibacterial capacities . HIF-1 activation in lung epithelial cells protects against VALI through optimization of carbohydrate metabolism . Our finding that HIF-1 knockdown augments hypoxia-induced increase in CXCL-1 secretion from lung epithelial cells suggests that HIF-1 activation in atelectatic lungs may be a protective response to hypoxia and prevents lung inflammation and injury. Further investigations on the roles of HIF-1 in lung injury are warranted.
Alveolar hypoxia in the atelectatic lung may be a novel therapeutic target for VALI. Our results support the rationale for open lung approaches, including application of higher PEEP and lung recruitment maneuvers. The clinical benefits of the open lung approach  may contribute to the improvement of alveolar hypoxia. On the other hand, the increase of the inspired O2 fraction may also increase alveolar oxygen tension even when atelectasis exists . Although it is possible that higher oxygen concentration shows toxic effects, increasing inspired O2 fraction may be able to attenuate hypoxia-induced inflammatory responses in the atelectatic lung region. Clinical trials to investigate optimal strategies to adjust the inspired O2 fraction are thus warranted.
This study has several limitations. First, the differential-ventilation model may not accurately reflect uneven mechanical ventilation in clinical settings, although it has some advantages as described previously. Second, although the systemic circulation was not severely impaired by ULV, we could not control pulmonary circulation during ULV. Pulmonary hypertension in response to alveolar hypoxia in atelectatic lungs may have contributed to lung injury [40, 41]. However, our in vitro observation that hypoxia significantly increases CXCL-1 secretion from lung epithelial cells strongly suggests that alveolar hypoxia is one of the main causes of inflammatory responses in atelectatic lungs. Third, the follow-up period was up to 8 h, and we did not evaluate any functional outcomes, such as mortality. Further investigations are needed to evaluate long-term effects of alveolar hypoxia in the atelectatic lungs on VALI. Fourth, we evaluated the contributions of NF-κB and HIF-1 to hypoxia-induced lung inflammation only in a lung epithelial cell line and by considering a single inflammatory mediator in vitro. Although, the critical role of CXCL-1 for the pathogenesis of VALI has been reported , further studies using animals and another cell types are needed.
Atelectasis causes alveolar hypoxia-induced inflammatory responses including NF-κB-dependent CXCL-1 secretion from lung epithelial cells. HIF-1 activation in lung epithelial cells is an anti-inflammatory response to alveolar hypoxia in atelectatic lungs. Modulation of HIF-1α and NF-κB in lung epithelial cells may present therapeutic approaches for VALI.
Atelectasis causes alveolar hypoxia-induced inflammatory responses including NF-κB-dependent CXCL-1 secretion from lung epithelial cells.
HIF-1 activation in lung epithelial cells is an anti-inflammatory response to alveolar hypoxia in atelectatic lungs.
- ACTB :
analysis of variance
bilateral lung ventilation
chemokine (C-C motif) ligand 2
chemokine (C-X-C motif) ligand 1
enzyme-linked immunosorbent assay
fetal bovine serum
- GLUT1 :
hypoxia-inducible factor 1
high tidal volume
inhibitors of κB
mean arterial pressure
normal tidal volume
- PaCO2 :
arterial partial pressure of carbon dioxide
- PaO2 :
arterial partial pressure of oxygen
- P aw :
positive end-expiratory pressure
quantitative polymerase chain reaction
small interfering RNA
tumor necrosis factor α
unilateral lung ventilation
ventilator-associated lung injury
- VEGFA :
vascular endothelial growth factor A
Tsuchida S, Engelberts D, Peltekova V et al (2006) Atelectasis causes alveolar injury in nonatelectatic lung regions. Am J Respir Crit Care Med 174:279–289. doi:10.1164/rccm.200506-1006OC
Retamal J, Bergamini B, Carvalho AR et al (2014) Non-lobar atelectasis generates inflammation and structural alveolar injury in the surrounding healthy tissue during mechanical ventilation. Crit Care 18:505. doi:10.1186/s13054-014-0505-1
Muscedere JG, Mullen JB, Gan K, Slutsky AS (1994) Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 149:1327–1334. doi:10.1164/ajrccm.149.5.8173774
Taskar V, John J, Evander E et al (1997) Surfactant dysfunction makes lungs vulnerable to repetitive collapse and reexpansion. Am J Respir Crit Care Med 155:313–320. doi:10.1164/ajrccm.155.1.9001330
Halter JM, Steinberg JM, Gatto LA et al (2007) Effect of positive end-expiratory pressure and tidal volume on lung injury induced by alveolar instability. Crit Care 11:R20. doi:10.1186/cc5695
Morrell NW, Nijran KS, Biggs T, Seed WA (1995) Magnitude and time course of acute hypoxic pulmonary vasoconstriction in man. Respir Physiol 100:271–281. doi:10.1016/0034-5687(95)00002-U
Frohlich S, Boylan J, McLoughlin P (2013) Hypoxia-induced inflammation in the lung: a potential therapeutic target in acute lung injury? Am J Respir Cell Mol Biol 48:271–279. doi:10.1165/rcmb.2012-0137TR
Taylor CT (2008) Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J Physiol Lond 586:4055–4059. doi:10.1113/jphysiol.2008.157669
Eltzschig HK, Carmeliet P (2011) Hypoxia and inflammation. N Engl J Med 364:656–665. doi:10.1056/NEJMra0910283
Tak PP, Firestein GS (2001) NF-κB: a key role in inflammatory diseases. J Clin Invest 107:7–11. doi:10.1172/JCI11830
Cummins EP, Berra E, Comerford KM et al (2006) Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci U S A 103:18154–18159. doi:10.1073/pnas.0602235103
Semenza GL (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148:399–408. doi:10.1016/j.cell.2012.01.021
Sitkovsky MV, Lukashev D, Apasov S et al (2004) Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 22:657–682. doi:10.1146/annurev.immunol.22.012703.104731
Walmsley SR (2005) Hypoxia-induced neutrophil survival is mediated by HIF-1-dependent NF-B activity. J Exp Med 201:105–115. doi:10.1084/jem.20040624
Cramer T, Yamanishi Y, Clausen BE, et al. (2003) HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112:645–657. doi: 10.1016/S0092-8674(03)00154-5.
Peyssonnaux C, Datta V, Cramer T et al (2005) HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest 115:1806–1815. doi:10.1172/JCI23865
Peyssonnaux C, Cejudo-Martin P, Doedens A et al (2007) Cutting edge: essential role of hypoxia inducible factor-1α in development of lipopolysaccharide-induced sepsis. J Immunol 178:7516–7519
Ota S, Nakamura K, Yazawa T et al (2007) High tidal volume ventilation induces lung injury after hepatic ischemia-reperfusion. Am J Physiol Lung Cell Mol Physiol 292:L625–L631. doi:10.1152/ajplung.00151.2006
Matute-Bello G, Downey G, Moore BB et al (2011) An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 44:725–738. doi:10.1165/rcmb.2009-0210ST
Imai Y, Kawano T, Iwamoto S et al (1999) Intratracheal anti-tumor necrosis factor-alpha antibody attenuates ventilator-induced lung injury in rabbits. J Appl Physiol 87:510–515
Bertok S, Wilson MR, Morley PJ et al (2012) Selective inhibition of intra-alveolar p55 TNF receptor attenuates ventilator-induced lung injury. Thorax 67:244–251. doi:10.1136/thoraxjnl-2011-200590
de Prost N, Costa EL, Wellman T et al (2013) Effects of ventilation strategy on distribution of lung inflammatory cell activity. Crit Care 17:R175. doi:10.1186/cc12854
Vaneker M, Halbertsma FJ, van Egmond J et al (2007) Mechanical ventilation in healthy mice induces reversible pulmonary and systemic cytokine elevation with preserved alveolar integrity: an in vivo model using clinical relevant ventilation settings. Anesthesiology 107:419–426. doi:10.1097/01.anes.0000278908.22686.01
Kallet RH, Matthay MA (2012) Hyperoxic acute lung injury. Respir Care 58:123–141. doi:10.4187/respcare.01963
Thiel M, Chouker A, Ohta A et al (2005) Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol 3:e174. doi:10.1371/journal.pbio.0030174
Srinivasan HB, Vogel SM, Vidyasagar D, Malik AB (2000) Protective effect of lung inflation in reperfusion-induced lung microvascular injury. Am J Physiol Heart Circ Physiol 278:H951–H957
Kao SJ, Wang D, Yeh DY-W et al (2004) Static inflation attenuates ischemia/reperfusion injury in an isolated rat lung in situ. Chest 126:552–558. doi:10.1378/chest.126.2.552
Madjdpour C, Jewell UR, Kneller S et al (2003) Decreased alveolar oxygen induces lung inflammation. Am J Physiol Lung Cell Mol Physiol 284:L360–L367. doi:10.1152/ajplung.00158.2002
Chao J, Wood JG, Blanco VG, Gonzalez NC (2009) The systemic inflammation of alveolar hypoxia is initiated by alveolar macrophage-borne mediator(s). Am J Respir Cell Mol Biol 41:573–582. doi:10.1165/rcmb.2008-0417OC
Chao J, Donham P, van Rooijen N et al (2011) Monocyte chemoattractant protein-1 released from alveolar macrophages mediates the systemic inflammation of acute alveolar hypoxia. Am J Respir Cell Mol Biol 45:53–61. doi:10.1165/rcmb.2010-0264OC
Fitzpatrick SF, Tambuwala MM, Bruning U et al (2011) An intact canonical NF-κB pathway is required for inflammatory gene expression in response to hypoxia. J Immunol 186:1091–1096. doi:10.4049/jimmunol.1002256
Sarada S, Himadri P, Mishra C et al (2008) Role of oxidative stress and NFkB in hypoxia-induced pulmonary edema. Exp Biol Med (Maywood) 233:1088–1098. doi:10.3181/0712-RM-337
Textoris J, Beaufils N, Quintana G et al (2012) Hypoxia-inducible factor (HIF1α) gene expression in human shock states. Crit Care 16:R120. doi:10.1186/cc11414
Schäfer ST, Frede S, Winning S et al (2013) Hypoxia-inducible factor and target gene expression are decreased in patients with sepsis: prospective observational clinical and cellular studies. Anesthesiology 118:1426–1436. doi:10.1097/ALN.0b013e31828baa67
Xu M, Cao F, Liu L et al (2011) Tanshinone IIA-induced attenuation of lung injury in endotoxemic mice is associated with reduction of hypoxia-inducible factor 1α expression. Am J Respir Cell Mol Biol 45:1028–1035. doi:10.1165/rcmb.2011-0113OC
Yeh CH, Cho W, So EC et al (2011) Propofol inhibits lipopolysaccharide-induced lung epithelial cell injury by reducing hypoxia-inducible factor-1 expression. Br J Anaesth 106:590–599. doi:10.1093/bja/aer005
Thiel M, Caldwell CC, Kreth S et al (2007) Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS One 2:e853. doi:10.1371/journal.pone.0000853
Eckle T, Brodsky K, Bonney M et al (2013) HIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epithelium. PLoS Biol 11:e1001665. doi:10.1371/journal.pbio.1001665.s009
Briel M, Meade M, Mercat A et al (2010) Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 303:865–873. doi:10.1001/jama.2010.218
Duggan M, McNamara PJ, Engelberts D et al (2005) Oxygen attenuates atelectasis-induced injury in the in vivo rat lung. Anesthesiology 103:522–531
Duggan M, McCaul CL, McNamara PJ et al (2003) Atelectasis causes vascular leak and lethal right ventricular failure in uninjured rat lungs. Am J Respir Crit Care Med 167:1633–1640. doi:10.1164/rccm.200210-1215OC
Belperio JA, Keane MP, Burdick MD et al (2002) Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest 110:1703–1716. doi:10.1172/JCI15849
The authors would like to thank Yuki Yuba and Akiko Adachi (Department of Anesthesiology and Critical Care Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan) for technical assistance.
This study was supported in part by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research no. 23592303 (to KK).
The authors declare that they have no competing interests.
KT conceived of and designed the study, performed the animal and biochemical experiments, analyzed the data, and wrote and edited the manuscript. YN participated in the study design and performed the animal experiments. TY performed the histological analysis. TM participated in the study design and statistical analysis and edited the manuscript. YB and SO participated in the study design. TG participated in the study design and edited the manuscript. KK conceived of the study, participated in its design and coordination, and edited the manuscript. All authors read and approved the final manuscript.
About this article
Cite this article
Tojo, K., Nagamine, Y., Yazawa, T. et al. Atelectasis causes alveolar hypoxia-induced inflammation during uneven mechanical ventilation in rats. ICMx 3, 18 (2015). https://doi.org/10.1186/s40635-015-0056-z
- Alveolar hypoxia
- Ventilator-associated lung injury
- Proinflammatory cytokines
- Hypoxia inducible factor-1
- Nuclear factor-κB